These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma. Bisaccia E; Vonderheid EC; Geskin L Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276 [TBL] [Abstract][Full Text] [Related]
3. Photopheresis in pediatric patients with low-body weight using the UVAR XTS system. Hillen U; Meyer S; Schadendorf D; Kremens B J Dtsch Dermatol Ges; 2010 Jan; 8(1):32-7. PubMed ID: 19751224 [TBL] [Abstract][Full Text] [Related]
4. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. Kusztal M; Kłak R; Krajewska M; Boratyńska M; Patrzałek D; Klinger M Transplant Proc; 2011 Oct; 43(8):2941-2. PubMed ID: 21996195 [TBL] [Abstract][Full Text] [Related]
5. Do AshSplit haemodialysis catheters provide better flow rates in the long term? Keeling AN; O'Dwyer H; Lyon S; O'Kelly P; McGrath FP; Conlon PJ; Lee MJ Ren Fail; 2007; 29(6):721-9. PubMed ID: 17763168 [TBL] [Abstract][Full Text] [Related]
6. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure. Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140 [TBL] [Abstract][Full Text] [Related]
7. Vascular access recirculation in hemodialysis patients with two noncuffed, single-lumen, jugular catheters in the same jugular vein. Kovac J; Buturović-Ponikvar J; Ponikvar R Ther Apher Dial; 2009 Aug; 13(4):350-3. PubMed ID: 19695073 [TBL] [Abstract][Full Text] [Related]
8. Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells. Lazarus HM; Trehan S; Miller R; Fox RM; Creger RJ; Raaf JH Bone Marrow Transplant; 2000 Apr; 25(7):779-85. PubMed ID: 10745265 [TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621 [TBL] [Abstract][Full Text] [Related]
10. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital. Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106 [TBL] [Abstract][Full Text] [Related]
11. [Single-center retrospective analysis of extracorporal photopheresis in clinical practice : Peripheral venous compared to central venous access]. Hambsch J; Büttner S; Heck M; Nicolay JP; Felcht M; Booken N; Klemke CD Hautarzt; 2019 Mar; 70(3):193-203. PubMed ID: 30627743 [TBL] [Abstract][Full Text] [Related]
12. The impact of increased blood flow rates on recirculation in central venous hemodialysis catheters. Szabo J; Locking-Cusolito H Nephrol Nurs J; 2001 Dec; 28(6):639-41. PubMed ID: 12143473 [TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis: what is it and when should it be used? Scarisbrick J Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649 [TBL] [Abstract][Full Text] [Related]
15. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Schenk P; Rosenkranz AR; Wölfl G; Hörl WH; Traindl O Am J Kidney Dis; 2000 Jan; 35(1):130-6. PubMed ID: 10620554 [TBL] [Abstract][Full Text] [Related]
16. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819 [TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840 [TBL] [Abstract][Full Text] [Related]
18. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S; Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274 [TBL] [Abstract][Full Text] [Related]
19. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol. Nedelcu E; Ziman A; Fernando LP; Cook K; Bumerts P; Schiller G J Clin Apher; 2008; 23(2):66-73. PubMed ID: 18286495 [TBL] [Abstract][Full Text] [Related]
20. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis. Liu C; Shah K; Dynis M; Eby CS; Grossman BJ Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]